Articles in Patents
Shortly after the oral arguments between Monsanto and Bowman, WCL hosted both parties for a post argument discussion. Recently the Supreme Court ruled on the case, requiring annual purchases of Monsanto’s soybeans.
The Food and Drug Administration’s recent decision, which reasoned that the drug posed public health and safety concerns, creates serious patent implications with regard to generic drugs.
The Supreme Court will decide in June just how much human manipulation is involved in “isolated” gene sequences.
Vringo Inc. is appealing a federal court decision awarding it damages and future royalties from its suit against Google, AOL, and other companies for patent infringement, seeking an increase on the dollar amount awarded and an increase in the running royalty rate.
Some companies see patent trolls as the bane of their existence, while others see them as a weapon to be used against competitors.
Shanghai Internet technology company Zhizhen brought suit against Apple, Inc., claiming that Apple’s Siri infringed on its patent for “Xiaoi,” a chat robot system. Specifically, Zhizhen contends that Siri’s core technology—man-machine interaction—is based on the word chat robot system which Xiaoi patented.
On April 12, the Intellectual Property Brief held its 2nd Annual Symposium with one segment focused on the Transitional Program for Covered Business Method Patents, how this alternative to complex civil litigation has fared so far, and how it will be used going forward.
April 17th marks the one year anniversary of Twitter’s Innovator’s Patent Agreement (IPA). The agreement was created to remedy the string of patent wars, but has received sharp criticism from shareholders and managers.
Rackspace is going after alleged Patent Troll IPNav by actively filing suit against them to try and limit their ability to bring future patent suits against Rackspace.
The Supreme Court will hear oral arguments on April 15, 2013 in the Myriad case, which asks whether human genes are patentable.